Lyssikatos Joseph P
Enliven Therapeutics, Inc. · CHIEF SCIENTIFIC OFFICER
Lyssikatos Joseph P is listed in filings as CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 17, 2026, including sale activity. Recent filings connect the profile to Enliven Therapeutics, Inc. (ELVN). The current snapshot covers public activity from Jul 3, 2024 to Feb 17, 2026. Reported amounts are shown as $3.1M to $390.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $145k5k shares | SellFeb 6, 2026 | $29.04 | $53.20 |